-
Sat27Aug2022Tue30Aug2022Barcelona, Spain
-
Sun09Oct2022Tue11Oct2022
-
Thu13Oct2022Sat15Oct2022
Latest News
HRS 2022: Same day discharge “benefits AF ablation patients”
Results of a study presented at the Heart Rhythm Society’s 2022 annual meeting (HRS 2022, 29 April–1 May, San Francisco, USA) show that the...
Features
New data underpin drive towards earlier AF ablation strategies
Historically, catheter ablation has been reserved for atrial fibrillation (AF) patients who have failed to respond to, or tolerate antiarrhythmic drug therapy, electrophysiologist Dhiraj...
Q-FFICIENCY trial shows promise for temperature-controlled ablation
Use of temperature-controlled ablation for the treatment of atrial fibrillation (AF) is effective and highly efficient, according to Jose Osorio—the director of electrophysiology at...
Videos
Findings of the EAST-AFNET 4 trial, examining the benefit of early rhythm control therapy in patients with newly diagnosed atrial fibrillation (AF), should influence future guidelines for the treatment of AF patients.
This was the message of Paulus Kirchhof (Hamburg,...
